calendar
3,733 catalysts · 3,080 8k filing · 576 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion · 62 phase 2 initiation
next 91 dayslessmore
MonWedFri
3,733 catalysts · 3,080 8k filing · 576 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion · 62 phase 2 initiation
Canine milk replacer
Sponsor: EXTROVIS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: QUAGEN. Form: SYRUP. Route: ORAL
Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLENMARK SPECLT. Form: CREAM. Route: TOPICAL
Sponsor: MARKSANS PHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: GLENMARK PHARMS LTD. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL
Sponsor: IMPAX LABS. Form: CAPSULE. Route: ORAL
Status: Current. Reason: not specified. Form: Capsule
Status: Current. Reason: not specified. Form: Capsule
Status: Current. Reason: not specified. Form: Tablet
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Tablet, Chewable
Status: Current. Reason: not specified. Form: Tablet
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Irrigant
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Capsule
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Tablet
Status: Current. Reason: not specified. Form: Tablet
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Concentrate
Status: Current. Reason: not specified. Form: Injection
AI grant. $209,758. PI: Paul K Drain
AT grant. $601,259. PI: Ashley E. Mason
NS grant. $568,920. PI: Theresa Currier Thomas
CA grant. $496,357. PI: DANIEL J BRAT
AT grant. $170,640. PI: Julia E. Hooker
AI grant. $210,302. PI: William Evan Johnson
DK grant. $231,000. PI: Roger D. Cone
NS grant. $230,562. PI: Thuy Nguyen
ES grant. $117,747. PI: Rebecca Sugrue
Angio Packs (AMS6908E and AMS6908F)
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: ACCORD HLTHCARE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL
Status: Current. Reason: not specified. Form: Injection